An evaluation of the utility of LVdP/dt40, QA interval, LVdP/dtmin and Tau as indicators of drug-induced changes in contractility and lusitropy in dogs.
Saved in:
| Title: | An evaluation of the utility of LVdP/dt |
|---|---|
| Authors: | Pugsley MK; Purdue Pharma, LP, Cranbury, NJ, United States., Guth B; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Chiang AY; Eli Lilly and Company, Indianapolis, IN, United States., Doyle JM; Data Sciences International, St. Paul, MN, United States., Engwall M; Amgen, Thousand Oaks, CA, United States., Guillon JM; Sanofi, Vitry sur Seine, France., Hoffmann PK; Novartis, East Hanover, NJ, United States., Koerner JE; FDA, Washington, DC, United States., Mittelstadt SW; AbbVie, Abbott Park, IL, United States., Pierson JB; HESI, Washington, DC, United States., Rossman EI; GlaxoSmithKline, King of Prussia, PA, United States., Sarazan DR; Independent, Rhinelander, WI, United States., Parish ST; HESI, Washington, DC, United States. Electronic address: sparish@hesiglobal.org. |
| Source: | Journal of pharmacological and toxicological methods [J Pharmacol Toxicol Methods] 2017 May - Jun; Vol. 85, pp. 1-21. Date of Electronic Publication: 2017 Jan 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 9206091 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-488X (Electronic) Linking ISSN: 10568719 NLM ISO Abbreviation: J Pharmacol Toxicol Methods Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 28065821 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: An evaluation of the utility of LVdP/dt<subscript>40</subscript>, QA interval, LVdP/dt<subscript>min</subscript> and Tau as indicators of drug-induced changes in contractility and lusitropy in dogs. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pugsley+MK%22">Pugsley MK</searchLink>; Purdue Pharma, LP, Cranbury, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Guth+B%22">Guth B</searchLink>; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.<br /><searchLink fieldCode="AU" term="%22Chiang+AY%22">Chiang AY</searchLink>; Eli Lilly and Company, Indianapolis, IN, United States.<br /><searchLink fieldCode="AU" term="%22Doyle+JM%22">Doyle JM</searchLink>; Data Sciences International, St. Paul, MN, United States.<br /><searchLink fieldCode="AU" term="%22Engwall+M%22">Engwall M</searchLink>; Amgen, Thousand Oaks, CA, United States.<br /><searchLink fieldCode="AU" term="%22Guillon+JM%22">Guillon JM</searchLink>; Sanofi, Vitry sur Seine, France.<br /><searchLink fieldCode="AU" term="%22Hoffmann+PK%22">Hoffmann PK</searchLink>; Novartis, East Hanover, NJ, United States.<br /><searchLink fieldCode="AU" term="%22Koerner+JE%22">Koerner JE</searchLink>; FDA, Washington, DC, United States.<br /><searchLink fieldCode="AU" term="%22Mittelstadt+SW%22">Mittelstadt SW</searchLink>; AbbVie, Abbott Park, IL, United States.<br /><searchLink fieldCode="AU" term="%22Pierson+JB%22">Pierson JB</searchLink>; HESI, Washington, DC, United States.<br /><searchLink fieldCode="AU" term="%22Rossman+EI%22">Rossman EI</searchLink>; GlaxoSmithKline, King of Prussia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Sarazan+DR%22">Sarazan DR</searchLink>; Independent, Rhinelander, WI, United States.<br /><searchLink fieldCode="AU" term="%22Parish+ST%22">Parish ST</searchLink>; HESI, Washington, DC, United States. Electronic address: sparish@hesiglobal.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229206091%22">Journal of pharmacological and toxicological methods</searchLink> [J Pharmacol Toxicol Methods] 2017 May - Jun; Vol. 85, pp. 1-21. <i>Date of Electronic Publication: </i>2017 Jan 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9206091 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-488X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210568719%22">10568719 </searchLink><i>NLM ISO Abbreviation: </i>J Pharmacol Toxicol Methods <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28065821 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.vascn.2017.01.002 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1 Titles: – TitleFull: An evaluation of the utility of LVdP/dt40, QA interval, LVdP/dtmin and Tau as indicators of drug-induced changes in contractility and lusitropy in dogs. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pugsley MK – PersonEntity: Name: NameFull: Guth B – PersonEntity: Name: NameFull: Chiang AY – PersonEntity: Name: NameFull: Doyle JM – PersonEntity: Name: NameFull: Engwall M – PersonEntity: Name: NameFull: Guillon JM – PersonEntity: Name: NameFull: Hoffmann PK – PersonEntity: Name: NameFull: Koerner JE – PersonEntity: Name: NameFull: Mittelstadt SW – PersonEntity: Name: NameFull: Pierson JB – PersonEntity: Name: NameFull: Rossman EI – PersonEntity: Name: NameFull: Sarazan DR – PersonEntity: Name: NameFull: Parish ST IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2017 May - Jun Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 1873-488X Numbering: – Type: volume Value: 85 Titles: – TitleFull: Journal of pharmacological and toxicological methods Type: main |
| ResultId | 1 |
